Some falling stocks are down for good reasons, while others are primed for a rebound. Are these purported growth stocks running out of rocket fuel or just pumping their brakes?
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up.
PetIQ (PETQ) delivered earnings and revenue surprises of 28.57% and 4.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific (BSX) delivered earnings and revenue surprises of 9.30% and 7.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) delivered earnings and revenue surprises of 37.50% and 4.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SurModics (SRDX) delivered earnings and revenue surprises of 21.88% and 3.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
PETQ vs. BSX: Which Stock Is the Better Value Option?
PETQ vs. BSX: Which Stock Is the Better Value Option?